While an unexpected development for Poly it's seems as @hottod alluded to that our main competing product to BTM is likely to be unaffected by the plant shutdown. MTX on the other hand could get a little kick but don't discount the fact that the market MTX is aimed towards is a much more crowded space. We also need to finish the diabetic foot ulcer study so we have solid evidence and reimbursement codes.....bullish yes but work still to be done and not there yet.
While an unexpected development for Poly it's seems as @hottod...
-
- There are more pages in this discussion • 2,558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |